Cardiac Misc

Question 1

Name/class
Heparin

Answer 1

Heparin

Anticoagulant

Question 2

Indications

Heparin

Answer 2

To prevent thrombus formation in acute MI

Question 3

Name/class
Levophed

Answer 3

Norepinephrine

Sympathomimetic agent

Question 4

Name/class
Norepinephrine

Answer 4

Levophed

Sympathomimetic agent

Question 5

Description
Norepinephrine
Levophed

Answer 5

Norepinephrine is a naturally occurring catecholamine and causes vasoconstriction, cardiac stimulation, and increased blood pressure, myocardial oxygen demand, and coronary blood flow

Question 6

Indications
Norepinephrine
Levophed

Answer 6

Refractory hypotension and neurogenic shock

Question 7

Contraindications
Norepinephrine
Levophed

Answer 7

Hypotension due to uncorrected hypovolemia

Question 8

Precautions
Norepinephrine
Levophed

Answer 8

Hypertension, severe heart disease, elderly, MAO inhibitor therapy, monitor blood pressure frequently and infuse the drug through the largest vein available as it may cause tissue necrosis

Question 9

Dosage/route
Norepinephrine
Levophed

Answer 9

0.5 to 30 mcg/min IV, titrated to BP

Question 10

Pedi dose/route
Norepinephrine
Levophed

Answer 10

0.01 mcg/kg/min rarely used

Question 11

Description

Heparin

Answer 11

Heparin is a rapid onset anticoagulant enhancing the effects of antithrombin III and blocking the conversion of prothrombin to thrombin and fibrinogen to fibrin

Question 12

name/class
activase

Answer 12

alteplase recombinant, TPA

thrombolytic

Question 13

name/class
TPA

Answer 13

alteplase recombinant, activase

thrombolytic

Question 14

name/class
alteplase recombinant

Answer 14

TPA, Activase

Thromboltic

Question 15

indications
alteplase recombinant
TPA
Activase

Answer 15

to thrombolyse in acute myocardial infarction, acute ischemic stroke and pulmonary embolism

Question 16

contraindications
alteplase recombinant
TPA
Activase

Answer 16

active internal bleedin, suspected aortic dissection, traumatic CPR, recent hemorrhagic stroke(6 months), intracranial or intraspinial surgery or trauma(2 months), pregnancy, uncontrolled hypertension, or hypersensitivity to thrombolytics

Question 17

precautions
alteplase recombinant
TPA
Activase

Answer 17

recent major surgery, cerebral vascular disease, recent GI or GU bleeding, recent trauma, hypertension, patient>75 years, current oral anticoagulants or hemorrhagic ophthalmic conditions

Question 18

description
alteplase recombinant
TPA
Activase

Answer 18

recombinant DNA derived form of human TPA promotes thrombolysis by forming plasmin. plasmin in turn, degrades fibrin and fibrinogen and ultimately the clot

Question 19

name/class
tridail

Answer 19

nitroglycerin injection

vasodilator/nitrate

Question 20

name/class
nitroglycerin injection

Answer 20

tridil

vasodilator/nitrate

Question 21

description
tridil
nitroglycerin injection

Answer 21

relaxes blood vessels increasing the blood and oxygen supply to the heart

Question 22

indications
tridil
nitroglycerin injection

Answer 22

nitroglycerin infusions are sed to help relieve the pain associated with anginia that does not respond to oral treatment; to control BP; and to help treat congestive heart failure

Question 23

contraindications
tridil
nitroglycerin injection

Answer 23

hypotension, uncorrected hypovolemia, increased intracranial pressure, constrictive pericarditis and pericardial tamponade

Question 24

precautions/side effects
tridil
nitroglycerin injection

Answer 24

headache, severe hypotension, reflex tachycardia

Question 25

dose/route tridil nitroglycerin injection

Answer 25

0.2-1.5 mcg/kg/min

Question 26

``` name/class verapamil ```

Answer 26

isoptin,calan | calcium channel blocker

Question 27

``` name/class isoptin ```

Answer 27

verapamil, calan | calcium channel blocker

Question 28

``` name/class calan ```

Answer 28

verapamil, isoptin | calcium channel blocker

Question 29

description verapamil isoptin calan

Answer 29

verapamil is a calcium channel blocker that slows AV conduction, suppresses reentry dysrhythmias such as PSVT, and slows ventricular responses to atrial tachydysrhythmias verapamil also dilates coronary arteries and reduces myocardial oxygen demand

Question 30

indications verapamil isoptin calan

Answer 30

PVST refactory to adenosine, atrial flutter, and atrial fibrillation with rapid ventricullar response

Question 31

contraindications verapamil isoptin calan

Answer 31

severe hypotension, cardiogenic shock, 2nd pr 3rd degree heart block, CHF, Sinus node disease, and accessory AV pathways, WPW syndrome. It should not be administered to persons taking beta blockers

Question 32

precautions verapamil isoptin calan

Answer 32

MI with coronary artery occlusion or myocardial stenosis

Question 33

dose/route verapamil isoptin calan

Answer 33

2.5-5mg IV bolus over 2-3 min, then 5-10mg after 15-30 min to a max of 30mg in 30 min

Question 34

``` name/class vasopressin ```

Answer 34

pitressin | hormone,vasopressor

Question 35

``` name/class pitressin ```

Answer 35

vasopressin | hormone, vasopressor

Question 36

description vasopressin pitressin

Answer 36

vasopressin is a hormone with strong vasopressive and anti-diuretic properties but they may precipitate anginia and or AMI

Question 37

indications vasopressin pitressin

Answer 37

to increase peripheral vascular resistance in arrest (CPR) or to control bleeding from esophageal varices

Question 38

contraindications vasopressin pitressin

Answer 38

PVC's | 1st stage of labor

Question 39

precautions vasopressin pitressin

Answer 39

Epilepsy, Migrane, Heart failure, Anginia, vascular disease, hepatic impairment, elderly and children

Question 40

cardiac arrest dose/route vasopressin pitressin

Answer 40

40 units IV

Question 41

esophageal varices dose/route vasopressin pitressin

Answer 41

0.2 to 0.4 units/min IV drip

Question 42

``` name/class eptifibatide ```

Answer 42

integrilin | glycoprotein IIb/IIIa inhibitor, platelet aggregation inhibitor

Question 43

``` name/class integrilin ```

Answer 43

eptifibatide | glycoprotein IIb/IIIa inhibitor, platelet aggregation inhibitor

Question 44

description eptifibatide integrilin

Answer 44

prevents the aggregation of platelets by binding to the glycoprotein IIb/IIIa receptor preventing the binding of fibrinogen and Von Willebrand factors

Question 45

indications eptifibatide integrilin

Answer 45

unstable anginia and NSTEMI(ACS) being managed medically

Question 46

contraindications eptifibatide integrilin

Answer 46

any prior intracranial hemorrhage, known malignant intracranial neoplasm, suspected, aortic dissection, significant closed head trauma or facial trauma within 3 hours

Question 47

precautions/side effects eptifibatide integrilin

Answer 47

cerebral hemorrhage, pulmonary hemorrhage, hypotension, GI bleeding, internal bleeding, anaphylactic shock

Question 48

dose/route eptifibatide integrilin

Answer 48

medical management 180 ug/kg IV bolus over 1-2 min, followed by a 2ug/kg infusion for 72-96 hours

Question 49

``` name/class bumetanide ```

Answer 49

bumex | loop diuretic

Question 50

``` name/class bumex ```

Answer 50

bumetanide | loop diuretic

Question 51

description bumetanide bumex

Answer 51

a patent loop diuretic with a rapid onset and short duration of action. inhibits the re-absorption of sodium and chloride in the ascending limb of the loop of henle

Question 52

indications bumetanide bumex

Answer 52

pulmonary | CHF

Question 53

contraindications bumetanide bumex

Answer 53

hypersensitivity to bumetainide or sulfonamides, hypotension, anuria, electrolyte deficiencies, hepatic coma. USE CAUTION: hepatic cirrhosis, ascites, diabetes, hypersensitivity to furosemide

Question 54

dose/route bumetanide bumex

Answer 54

0.5-1.0 mg IV slowly over 1-2 min or IM

Question 55

pedi dose/route bumetanide bumex

Answer 55

safety and effectiveness in pediatrics is not established